Elyxium Wealth’s Idexx Laboratories IDXX Stock Holding History

Elyxium Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.29M	Sell	12,971 -5,406,536	-100%	-$3.47B	2.34%	8
2025 Q4	$5.44M	Buy	+5,419,507	New	+$3.69B	1.51%	15

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Elyxium Wealth's IDXX Position: Q1 2026 in Review

Elyxium Wealth reduced its Idexx Laboratories (IDXX) stake by 100% in Q1 2026, selling an estimated $3.47B and leaving 12,971 shares worth $7.29M. The position accounts for 2.34% of the portfolio, ranked #8.

Elyxium Wealth first reported a position in IDXX in Q4 2025 and has held it in 2 quarters since. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Elyxium Wealth held 12,971 shares of Idexx Laboratories worth $7.29M as of Q1 2026.
Elyxium Wealth sold 5,406,536 Idexx Laboratories shares in Q1 2026, an estimated $3.47B.
Idexx Laboratories made up 2.34% of Elyxium Wealth's portfolio in Q1 2026, its #8 holding.
Elyxium Wealth first reported a position in Idexx Laboratories in Q4 2025 and has held it in 2 quarters since.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Elyxium Wealth's 13F filing for Q1 2026, filed 6 May 2026.